1. Home
  2. BDC vs APGE Comparison

BDC vs APGE Comparison

Compare BDC & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belden Inc

BDC

Belden Inc

HOLD

Current Price

$137.59

Market Cap

4.5B

ML Signal

HOLD

Logo Apogee Therapeutics Inc.

APGE

Apogee Therapeutics Inc.

HOLD

Current Price

$134.59

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BDC
APGE
Founded
1902
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.5B
4.7B
IPO Year
1994
2023

Fundamental Metrics

Financial Performance
Metric
BDC
APGE
Price
$137.59
$134.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
13
Target Price
$162.50
$109.67
AVG Volume (30 Days)
484.9K
1.1M
Earning Date
04-30-2026
05-12-2026
Dividend Yield
0.16%
N/A
EPS Growth
23.13
N/A
EPS
3.04
N/A
Revenue
$2,715,194,000.00
N/A
Revenue This Year
$8.91
N/A
Revenue Next Year
$4.70
N/A
P/E Ratio
$44.70
N/A
Revenue Growth
10.33
N/A
52 Week Low
$98.00
$35.39
52 Week High
$159.99
$134.88

Technical Indicators

Market Signals
Indicator
BDC
APGE
Relative Strength Index (RSI) 73.08 76.53
Support Level $102.61 $134.03
Resistance Level $149.84 $134.88
Average True Range (ATR) 4.87 0.23
MACD 1.83 -0.92
Stochastic Oscillator 95.03 60.59

Price Performance

Historical Comparison
BDC
APGE

About BDC Belden Inc

Belden Inc is a supplier of complete connection solutions. It has two segments, Smart Infrastructure Solutions and Automation Solutions. Smart Infrastructure Solutions provides network infrastructure and broadband solutions, serving markets such as data centers, government, healthcare, and broadband and wireless service providers, with products including copper and fiber cable and connectivity solutions. Automation Solutions provides digitization and automation solutions that enable IT OT convergence and support acquisition, transmission, orchestration, and management, serving markets including Warehousing and Logistics, Energy, Transportation, and Discrete Manufacturing. The company operates in the Americas, EMEA, and APAC, with maximum revenue coming from the Americas.

About APGE Apogee Therapeutics Inc.

Apogee Therapeutics Inc is a clinical-stage biotechnology company engaged in advancing optimized, novel biologics with the potential for differentiated efficacy and dosing in the inflammatory and immunology (I&I) markets, including for the treatment of atopic dermatitis (AD), asthma, eosinophilic esophagitis (EoE), chronic obstructive pulmonary disease (COPD), and other I&I indications. . Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.

Share on Social Networks: